Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.20.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2019
May 14, 2020
Jun. 30, 2019
Details      
Registrant CIK 0001514946    
Fiscal Year End --12-31    
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2019    
Document Transition Report false    
Entity File Number 000-54296    
Entity Registrant Name AXIM Biotechnologies, Inc.    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 27-4029386    
Entity Address, Address Line One 45 Rockefeller Plaza    
Entity Address, Address Line Two 20th Floor, Suite 83    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10111    
Entity Address, Address Description Address of principal executive offices    
Phone Fax Number Description Registrant’s telephone number, including area code    
City Area Code 212    
Local Phone Number 332-1677    
Entity Listing, Par Value Per Share $ 0.0001    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 6,215,518
Entity Common Stock, Shares Outstanding   128,438,640  
Amendment Flag false    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY